Activation of NF-κB by HDAC inhibitor apicidin through Sp1-dependent de novo protein synthesis: Its implication for resistance to apoptosis

Cell Death and Differentiation

Volumn 13, Issue 12, 2006, Pages 2033-2041

  Kim, Y K ^a   Lee, E K ^b   Kang, J K ^b   Kim, J A ^b   You, J S ^b   Park, J H ^b   Seo, D W ^c   Hwang, J W ^a   Kim, S N ^d   Lee, H Y ^e   Lee, H W ^b   Han, J W ^b  

^a Catholic Kwandong University   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Kangwon National University   (South Korea)

^d Korea Institute of Science and Technology   (South Korea)

^e Konyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APICIDIN; HISTONE; HISTONE DEACETYLASE INHIBITOR; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; INTERLEUKIN 8; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR SP1; CYCLOPEPTIDE; HISTONE DEACETYLASE; I KAPPA B KINASE; INHIBITOR OF APOPTOSIS PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL FATE; CELL PROTECTION; CELL TYPE; CONTROLLED STUDY; DRUG ACETYLATION; DRUG MECHANISM; DRUG RESPONSE; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; GENE TARGETING; HELA CELL; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENETICS; METABOLISM; PHYSIOLOGY;

APOPTOSIS; FEMALE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HELA CELLS; HISTONE DEACETYLASES; HUMANS; I-KAPPA B KINASE; INHIBITOR OF APOPTOSIS PROTEINS; INTERLEUKIN-8; NF-KAPPA B; PEPTIDES, CYCLIC; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR;

EID: 33750998178     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401915     Document Type: Article

References (42)

1. Marks PA, Richon VM, Breslow R and Rifkind RA (2001) Histone deacetylase inhibitors as new cancer drugs. Curr. Opin. Oncol. 13: 477-483.
2. Cip1 and gelsolin. Cancer Res. 60: 6068-6074.
3. Kwon SH, Ahn SH, Kim YK, Bae GU, Yoon JW, Hong S, Lee HY, Lee YW, Lee HW and Han JW (2002) Apicidin, a histone deacetylase inhibitor, induces apoptosis and Fas/Fas ligand expression in human acute promyelocytic leukemia cells. J. Biol. Chem. 277: 2073-2080.
4. Marks PA, Richon VM and Rifkind RA (2000) Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells. J. Natl. Cancer Inst. 92: 1210-1216.
5. Van Lint C, Emiliani S and Verdin E (1996) The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr 5: 245-253.
6. WAF1/Cip1 transcription through Sp1 Sites by histone deacetylase inhibitor apicidin: Involvement of protein kinase C. J. Biol. Chem. 276: 42084-42090.
7. WAF1/Cip1 through Sp1 sites by histone deacetylase inhibitor apicidin requires PI 3-kinase-PKεsignaling pathway. Oncogene 22: 6023-6031.
8. WAF1/CIP1 gene transcription in human colorectal adenocarcinoma cells. Int. J. Cancer 109: 207-213.
9. Xu Y (2003) Regulation of p53 responses by post-translational modifications. Cell Death Differ. 10: 400-403.
10. Chen L, Fischle W, Verdin E and Greene WC (2001) Duration of nuclear NF-κB action regulated by reversible acetylation. Science 293: 1653-1657.
11. Mayo MW, Denlinger CE, Broad RM, Yeung F, Reilly ET, Shi Y and Jones DR (2003) Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-β through the Akt pathway. J. Biol. Chem. 278: 18980-18989.
12. Baldwin Jr AS (1996) The NF-κB and IκB proteins: New discoveries and insights. Annu. Rev. Immunol. 14: 649-683.
13. Ghosh S, May MJ and Kopp EB (1998) NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16: 225-260.
14. Tang G, Minemoto Y, Dibling B, Purcell NH, Li Z, Karin M and Lin A (2001) Inhibition of JNK activation through NF-κB target genes. Nature 414: 313-317.
15. Finco TS, Beg AA and Baldwin Jr AS (1994) Inducible phosphorylation of IκBα is not sufficient for its dissociation from NF-κB and is inhibited by protease inhibitors. Proc. Natl. Acad. Sci. USA 91: 11884-11888.
16. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D and Miyamoto S (1995) Rel/NF-κB/IκB family: Intimate tales of association and dissociation. Genes Dev. 9: 2723-2735.
17. Carlotti F, Dower SK and Qwarnstrom EE (2000) Dynamic shuttling of nuclear factor kappa B between the nucleus and cytoplasm as a consequence of inhibitor dissociation. J. Biol. Chem. 275: 41028-41034.
18. Huang TT, Kudo N, Yoshida M and Miyamoto S (2000) A nuclear export signal in the N-terminal regulatory domain of IκBAa controls cytoplasmic localization of inactive NF-κB/IκBα complexes. Proc. Natl. Acad. Sci. USA 97: 1014-1019.
19. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E and Karin M (1997) A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388: 548-554.
20. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa M, Mann M, Manning A and Rao A (1997) IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278: 860-866.
21. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z and Rothe M (1997) Identification and characterization of an IκB kinase. Cell 90: 373-383.
22. Zandi E, Rothwarf DM, Delhase M, Hayakawa M and Karin M (1997) The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91: 243-252.
23. Finco TS and Baldwin AS (1995) Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity 3: 263-272.
24. Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y and Collins T (1997) CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl. Acad. Sci. USA 94: 2927-2932.
25. Perkins ND, Felzien LK, Betts JC, Leung K, Beach DH and Nabel GJ (1997) Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 275: 523-527.
26. Zhong H, Voll RE and Ghosh S (1998) Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1: 661-671.
27. Na SY, Lee SK, Han SJ, Choi HS, Im SY and Lee JW (1998) Steroid receptor coactivator-1 interacts with the p50 subunit and coactivates nuclear factor-kappaB-mediated transactivations. J. Biol. Chem. 273: 10831-10834.
28. Sheppard KA, Phelps KM, Williams AJ, Thanos D, Glass CK, Rosenfeld MG, Gerritsen ME and Collins T (1998) Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1. J. Biol. Chem. 273: 29291-29294.
29. Sheppard KA, Rose DW, Haque ZK, Kurokawa R, McInerney E, Westin S, Thanos D, Rosenfeld MG, Glass CK and Collins T (1999) Transcriptional activation by NF-κB requires multiple coactivators. Mol. Cell. Biol. 19: 6367-6378.
30. Ashburner BP, Westerheide SD and Baldwin Jr AS (2001) The p65 (RelA) subunit of NF-κB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol. Cell. Biol. 21: 7065-7077.
31. Baek SH, Ohgi KA, Rose DW, Koo EH, Glass CK and Rosenfeld MG (2002) Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-κB and beta-amyloid precursor protein. Cell 110: 55-67.
32. Zhong H, May MJ, Jimi E and Ghosh S (2002) The phosphorylation status of nuclear NF-κB determines its association with CBP/p300 or HDAC-1. Mol. Cell 9: 625-636.
33. Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F, Kirk HE, Kay RJ and Israel A (1998) Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell 93: 1231-1240.
34. Hu Y, Baud V, Delhase M, Zhang P, Deerinck T, Ellisman M, Johnson R and Karin M (1999) Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase. Science 284: 316-320.
35. Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M, Johnson R and Karin M (1999) The IKKβ subunit of IκB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J. Exp. Med. 189: 1839-1845.
36. Taniura S, Kamitani H, Watanabe T and Eling TE (2002) Transcriptional regulation of cyclooxygenase-1 by histone deacetylase inhibitors in normal human astrocyte cells. J. Biol. Chem. 277: 16823-16830.
37. Hou M, Wang X, Popov N, Zhang A, Zhao X, Zhou R, Zetterberg A, Bjorkholm M, Henriksson M, Gruber A and Xu D (2002) The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells. Exp. Cell Res. 274: 25-34.
38. Dai Y, Rahmani M, Dent P and Grant S (2005) Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-κB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation. Mol. Cell. Biol. 25: 5429-5444.
39. Adam E, Quivy V, Bex F, Chariot A, Collette Y, Vanhulle C, Schoonbroodt S, Goffin V, Nguyen TL, Gloire G, Carrard G, Friguet B, De Launoit Y, Burny A, Bours V, Piette J and Van Lint C (2003) Potentiation of tumor necrosis factor-induced NF-κB activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of IκBα. Mol. Cell. Biol. 23: 6200-6209.
40. Chen LF and Greene WC (2003) Regulation of distinct biological activities of the NF-κB transcription factor complex by acetylation. J. Mol. Med. 81: 549-557.
41. WAF1 expression and gene-associated histone acetylation. Proc. Natl. Acad. Sci. USA 97: 10014-10019.
42. Park JS, Lee KR, Kim JC, Lim SH, Seo JA and Lee YW (1999) A hemorrhagic factor (apicidin) produced by toxic Fusarium isolates from soybean seeds. Appl. Environ. Microbiol. 65: 126-130.